Skip to content

Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study

Diagnosis of Monoclonal Gammopathy of Renal Significance in Patients With Paraproteinemias

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03629561
Acronym
MGRS-CAPS
Enrollment
15
Registered
2018-08-14
Start date
2019-02-23
Completion date
2021-02-28
Last updated
2019-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monoclonal Gammopathy of Renal Significance

Keywords

Paraproteinemias[Mesh], Kidney Diseases[Mesh]

Brief summary

This is the first prospective study which evaluate patients with small B-cell clones to diagnose monoclonal gammopathy of renal significance (MGRS) and characterize it clinically, anatomopathologically and pathophysiologically taking int account a geriatric approach.

Interventions

None listed

Sponsors

Academia Nacional de Medicina
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Paraproteinemias

Exclusion criteria

* Multiple Myeloma * Waldenstrom Macroglobulinemia * Chronic Lymphocytic Leukemia * Malignant Lymphoma * Monoclonal gammopathy of unknown significance (MGUS) secondary to Infections * MGUS secondary to Autoimmune Diseases * Uncompleted hematological evaluation * Renal tumor except for cysts Bosniak type I/II * Other malignant neoplasia * Unresolved obstructive uropathy * Patients with only one kidney except for renal transplant * Co-morbidities which would limit the ability to receive aggressive therapeutic intervention * Fragile old people * Pregnancy * Prison * Impatient in psychiatric institutions.

Design outcomes

Primary

MeasureTime frame
Renal histopathology compatible with MGRSthrough study completion, an average of 1 year

Secondary

MeasureTime frame
Renal physiopathological changesthrough study completion, an average of 1 year

Countries

Argentina

Contacts

Primary ContactMariana Ciocchini, Nephrologist
marianaciocchini@pm.me+54 9 11 6172 2738

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026